Sex differences in clinical trial enrollment in the United States across psychiatric disorders

CONCLUSIONS: Enrollment disparities by sex were observed for psychiatric drug clinical trials, with male and female participants underrepresented in different areas of research. Most disorders have not demonstrated progress toward improving representation over time. Psychiatric disorders with unequal and disproportionate enrollment may benefit from support to improve representation.

via https://pubmed.ncbi.nlm.nih.gov/40834925/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20250831011006&v=2.18.0.post9+e462414